Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 26,667 | 11,824 | 0 | 0 |
| Operating Income | -26,667 | -11,824 | N/A | N/A |
| Other Income | 144 | 6,724 | 0 | 0 |
| Pre-tax Income | -26,523 | -5,100 | 0 | 0 |
| Net Income Continuous | -26,523 | -5,100 | N/A | N/A |
| Net Income | $-26,523 | $-5,100 | $N/A | $N/A |
| EPS Basic Total Ops | -24.00 | -5.47 | N/A | N/A |
| EPS Basic Continuous Ops | -24.00 | -5.47 | N/A | N/A |
| EPS Diluted Total Ops | -24.00 | -5.47 | N/A | N/A |
| EPS Diluted Continuous Ops | -24.00 | -5.47 | N/A | N/A |
| EBITDA(a) | $-26,341 | $-11,720 | $N/A | $N/A |